A new lifesaving treatment for people suffering from vaccine-related blood clots has been demonstrated by researchers at the McMaster Platelet Immunology Laboratory (MPIL)
Infectious disease and hematology experts answer questions about rare vaccine-related blood clots, including risks, symptoms and whether people who have had one AstraZeneca shot should have a second.
Behind the scenes at the McMaster Platelet Immunology Laboratory, scientists are studying a cell so tiny it was once called 'blood dust'.
McMaster logo
McMaster logo
